JPMorgan raises target for Givaudan stock to CHF 3,700

Published on 10/01/2026 at 12:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sales reached CHF 3,799 million in the first half of 2026, up 3.6 percent. Givaudan stock costs EUR 3,576.00 on October 1, 2026 after EUR 3,583.50.

Givaudan CH0010645932 fotorealistisches Parfumeur-Atelier mit Reagenzgläsern, getrockneten Blüten und warmem goldenem Nachmittagslicht, Illustration mit AI erstellt.

Givaudan stock (ISIN CH0010645932) was trading at EUR 3,576.00 at Lang & Schwarz on October 1, 2026 at 12:07 p.m. CEST, while JPMorgan raised its price target from CHF 3,600.00 to CHF 3,700.00 on September 22, 2026. According to Markets Insider, analyst Celine Pannuti maintained an Overweight rating alongside the target increase.

JPMorgan lifts the valuation mark

The CHF 100.00 target increase gives JPMorgan's view a concrete reference point ahead of Givaudan's third-quarter sales update. The target is in Swiss francs, so it is separate from the EUR 3,576.00 Lang & Schwarz quote used for German investors.

MarketScreener reports that Jefferies moved Givaudan from Buy to Neutral on September 1, 2026 and cut its target from CHF 3,700.00 to CHF 3,030.00. That split in analyst views places more weight on the next operating update than on a single target.

Half-year sales grew 3.6 percent

Givaudan reported sales of CHF 3,799 million for the first half of 2026, with like-for-like sales growth of 3.6 percent. The figures come from Givaudan and show that the company expanded against the prior-year comparison while adjusted free cash flow stood at minus 3.1 percent of sales.

The company also reported full-year 2025 sales of CHF 7,472 million, up 5.1 percent on a like-for-like basis, alongside EBITDA of CHF 1,751 million and a 23.4 percent EBITDA margin. Those historical fiscal-year figures provide a profitability benchmark, while the first-half 2026 sales growth is the more recent operating measure.

Stock stays below the Swiss yearly high

On the SIX Swiss Exchange, Givaudan was quoted at CHF 3,372.00 on October 1, 2026 at 11:57 a.m. CEST, against a 52-week range of CHF 2,566.00 to CHF 3,592.00. The CHF 31.1 billion market capitalization gives the company a large-cap profile in the specialty chemicals sector.

At Lang & Schwarz, the EUR 3,576.00 price was down 0.21 percent versus the prior close of EUR 3,583.50 on September 30, 2026. The further course of trading is shown by the continuously updated real-time quote of Givaudan stock.